遵守地中海饮食和帕金森病之间的关联:系统性审查和元分析
Jiarui Zhao1, Yuan Peng2, Zhenfang Lin3
1College of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, No. 1166, Liutai Avenue West, Chengdu, Sichuan Province, China.
The journal of nutrition, health & aging
|December 18, 2024
概括
坚持地中海饮食 (MD) 显著降低了帕金森病 (PD) 的风险. 这种饮食模式在预防前发性帕金森病方面尤其有效.
科学领域:
- 神经科学是一个神经科学.
- 营养流行病学 营养流行病学
- 预防医学 预防医学
背景情况:
- 帕金森病 (PD) 是一种慢性神经退行性疾病,患病率越来越高.
- 以前的研究表明,地中海饮食 (MD) 坚持与PD风险之间存在潜在联系,但研究结果不一致.
- 这一元分析探讨了关于长期MD坚持和PD发生率之间的关联的不同结论.
研究的目的:
- 系统地评估遵守地中海饮食 (MD) 与患帕金森病 (PD) 的风险之间的关联.
- 使用元分析方法量化高MD坚持对PD发病率的保护作用.
主要方法:
- 在主要数据库 (PubMed,Embase,Web of Science,Cochrane) 进行了全面的文献搜索,截至2024年2月.
- 包括观察性研究 (队列,病例控制,横截面) 用得分或指数量化MD坚持.
- 随机效应模型被用来计算汇集的几率比率 (ORs) 和95%置信区间 (CI) 对于最高和最低的MD坚持类别.
主要成果:
- 对MD的最高坚持与PD风险降低有显著关联 (OR = 0.75;95% CI:0.66,0.84).
- 这种保护性关联在被诊断的PD (OR = 0.83;95% CI: 0.74,0.94) 和预发性PD (pPD) (OR = 0.67;95% CI: 0.59,0.76) 均被观察到.
- 在不同年龄组中注意到保护作用,在年轻人 (<60岁) 中效果更强烈.
结论:
- 坚持地中海饮食表明对帕金森病发病率有显著的保护作用.
- MD可能是预防PD的关键饮食策略,特别是在早期的前性阶段.
- 进一步的研究和促进MD的公共卫生倡议可以帮助减轻PD风险.
相关概念视频
Parkinson's Disease: Treatment
235
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Parkinson's Disease: Overview
495
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3


